Compare TCBX & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | TCBX | YDES |
|---|---|---|
| Founded | 2008 | 2013 |
| Country | United States | Taiwan |
| Employees | N/A | N/A |
| Industry | Banks | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 628.8M | 543.0M |
| IPO Year | 2021 | N/A |
| Metric | TCBX | YDES |
|---|---|---|
| Price | $36.87 | $5.08 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $45.00 | N/A |
| AVG Volume (30 Days) | ★ 71.2K | 16.8K |
| Earning Date | 04-22-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 36.33 | N/A |
| EPS | ★ 0.88 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $29.99 | N/A |
| Revenue Next Year | $10.14 | N/A |
| P/E Ratio | $42.21 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $29.68 | $4.73 |
| 52 Week High | $43.84 | $25.00 |
| Indicator | TCBX | YDES |
|---|---|---|
| Relative Strength Index (RSI) | 40.36 | 37.86 |
| Support Level | $36.39 | $4.73 |
| Resistance Level | $38.86 | $5.37 |
| Average True Range (ATR) | 1.08 | 0.23 |
| MACD | -0.12 | 0.10 |
| Stochastic Oscillator | 23.53 | 47.95 |
Third Coast Bancshares Inc is a bank holding company. It focuses on providing commercial banking solutions to small and medium-sized businesses and professionals with operations in its markets. The bank operates twenty branches in the Greater Houston, Dallas-Fort Worth, and Austin-San Antonio markets, one branch in Ballinger, Texas, and one branch in Detroit, Texas. The company operates through one segment, community banking, It generates the majority of its revenue from interest on loans, customer service, and loan fees.
YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.